Lazard related stories
All articles and analysis
Swander Pace raises $350mThe mid-market firm has made three investments from the fund.
- Ardian sells Diana for €1.3bn
The business attracted bids from The Blackstone Group, BC Partners, Eurazeo, CVC and Pamplona.
- Montagu in €300m healthcare deal
The acquisition of Arkopharma is Montagu’s third healthcare investment this year.
- Lazard hires Atlantic-Pacific exec
Sarah Sandstrom has moved from the placement agent to become a managing director in Lazard’s New York office.
- Avista, Nordic seal $439m pharma take-private
The investment comes as Avista seeks $2bn for its third fund and Nordic targets €3bn for its Fund VIII.
- Equistone IV holds €1.5bn final close
Forty-two LPs committed to the European mid-market firm’s latest fund, closed roughly one year after its spin-out from Barclays.
- Kohlberg hits $1.6bn hard-cap
The firm surpassed its $1.5bn target by attracting commitments from more than 50 limited partners, more than 20% of which are non-US investors.
- Bain to acquire Maison du Monde
The US firm will buy the French furniture retailer from Apax, LBO France, and NiXEN, in a deal valued at between €650m and €700m.
- Abraaj divests Turkish health insurance business
The Dubai-based firm has agreed to sell its stake in a Turkish health insurance business after investing in the company in 2007.
- Avedon closes first independent fund on €190m
The firm, which spun out from NIBC Bank in 2011, has been backed by LPs like Adveq, Access Capital Partners, Goldman Sachs and Macquarie Group.